Latest filing published 27 Aug 2026 for Gilead Sciences, INC., €401k.
Anthony Welters serves as a Director at Loews Corp (28 filings), Carlyle Group Inc. (16), Gilead Sciences, Inc. (12) and Bard C R Inc /NJ/ (11). The record has 67 filings between February 18, 2016 and August 27, 2026, 16 of them in 2024, the maximum.
The 11 sales total EUR 3.0 million, with a median of EUR 99,851. The three largest, all at Gilead Sciences, Inc., carry the date August 26, 2026: EUR 877,073, EUR 586,420 and EUR 431,980. No purchase is in the record, which holds 21 option exercises, 19 grants and 16 lines of another nature.
Nine filings fall in the last 12 months, 4 of them sales. The median publication delay is 1 day, across 67 dated filings.
Four Loews Corp colleagues, Ann E. Berman, Charles M. Diker, Paul J. Fribourg and Walter L. Harris, each traded close to 6 of Welters's trades, in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 67 declarations